H.C. Wainwright analyst Emily Bodnar has reiterated their neutral stance on GERN stock, giving a Hold rating on July 29.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Emily Bodnar’s rating is based on Geron’s recent financial performance and market dynamics. The company’s Rytelo revenues showed improvement in the second quarter of 2025, surpassing previous estimates. However, the revenue growth compared to the fourth quarter of 2024 was modest, and the company has indicated potential variability in demand and inventory levels, which suggests that sustained growth might take more time to establish.
Additionally, while there is an increase in the number of active ordering accounts and favorable reimbursement coverage, the distribution between first-line, second-line, and third-line treatments remains a concern. The company’s efforts to expand in the European market are also contingent on securing favorable reimbursement rates, which adds another layer of uncertainty. These factors contribute to the Hold rating as the company needs to demonstrate consistent revenue growth and overcome these challenges before a more optimistic rating can be considered.
In another report released on July 29, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $1.00 price target.